Evidence map›Paper›PMID 31831039›Full record

ArticleCritical care (London, England)2019

Effect of high-dose vitamin C therapy on severe burn patients: a nationwide cohort study.

Mikio Nakajima, Morita Kojiro, Shotaro Aso, Hiroki Matsui, Kiyohide Fushimi, Yasuhiko Kaita, Hideaki Goto, Yoshihiro Yamaguchi, Hideo Yasunaga

Registry-linked trialAbstract readLetterComment
In one paragraph

Article in Critical care (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07329595 (Monitoring the Clinical and Immunological Effects of Microbiome Changes Following Severe Burn Injury), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07329595 recruitingnot on this mapstarted 2023, after this paper: background citation

Monitoring the Clinical and Immunological Effects of Microbiome Changes Following Severe Burn Injury

TypeobservationalSponsorTamas Vegh, MDRan2023 to 2026Enrolled30ConditionsSeverely Burned Patients, Gut Microbiota Diversity and Composition, Inflammatory Responses
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Vitamin therapy in sepsis.Pediatric research · 2022
    Review
  15. Article
  16. Vitamin C: a misunderstood ally?Critical care (London, England) · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Mikio NakajimaEmergency and Critical Care Center, Tokyo Metropolitan Hiroo Hospital, 2-34-10, Ebisu, Shibuya-ku, Tokyo, 150-0013, Japan. mikioh@ks.kyorin-u.ac.jp.ORCID 0000-0002-2903-1092
Morita KojiroDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Shotaro AsoDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Hiroki MatsuiDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Kiyohide FushimiDepartment of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Yasuhiko KaitaDepartment of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Hideaki GotoEmergency and Critical Care Center, Tokyo Metropolitan Hiroo Hospital, 2-34-10, Ebisu, Shibuya-ku, Tokyo, 150-0013, Japan.
Yoshihiro YamaguchiDepartment of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.

Funding

Ministry of Health, Labour and Welfare H29-ICT-General-004 and H30-Policy-Designated-004The Ministry of Education, Culture, Sports, Science and Technology, Japan 17H04141
6 · The paper itself

Abstract

backgroundVitamin C is a well-documented antioxidant that reduces oxidative stress and fluid infusion in high doses; however, the association between high-dose vitamin C and reduced mortality remains unclear. This study evaluates the effect of high-dose vitamin C in severe burn patients under two varying thresholds.

methodsWe enrolled adult patients with severe burns (burn index ≥ 15) who were registered in the Japanese Diagnosis Procedure Combination national inpatient database from 2010 to 2016. Propensity score matching was performed between patients who received high-dose vitamin C within 1 day of admission (vitamin C group) and those who did not (control group). High-dose vitamin C was defined as a dosage in excess of 10 g or 24 g within 2 days of admission. The primary outcome was in-hospital mortality.

resultsEligible patients (n = 2713) were categorized into the vitamin C group (n = 157) or control group (n = 2556). After 1:4 propensity score matching, we compared 157 and 628 patients who were administered high-dose vitamin C (> 10-g threshold) and controls, respectively. Under this particular threshold, high-dose vitamin C therapy was associated with reduced in-hospital mortality (risk ratio, 0.79; 95% confidence interval, 0.66-0.95; p = 0.006). In contrast, in-hospital mortality did not differ between the control and high-dose vitamin C group under the > 24-g threshold (risk ratio, 0.83; 95% confidence interval, 0.68-1.02; p = 0.068).

conclusionsHigh-dose vitamin C therapy was associated with reduced mortality in patients with severe burns when used under a minimum threshold of 10 g within the first 2 days of admission. While "high-dose" vitamin C therapy lacks a universal definition, the present study reveals that different "high-dose" regimens may yield improved outcomes.

Indexed as

BurnsCritical IllnessAdultAscorbic AcidCephalosporinsCohort StudiesContinuous Renal Replacement TherapyHumansTazobactamAscorbic AcidceftolozaneCephalosporinsTazobactamAscorbic acidBurnCompeting riskMatchingPropensity scoreVitamin C

Identifiers

PMID31831039
PMCPMC6909452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.